Condition
Crohn's disease news across medications, symptoms, tests, procedures, complications, research, access, and daily life.
Page 4 of 18 · 826 articles
A book describing a personal recovery from Crohn’s through diet, fitness, and faith may interest people looking for lifestyle approaches or peer experiences. It’s not clinical evidence but could offer practical ideas or...
Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Ulcerative colitis, Crohn's disease, and Inflammatory bowel disease. Open the original article for...
Many people with Crohn’s ask whether specific diets can reduce inflammation rather than only avoiding triggers. This randomized trial reports symptom and stool-marker improvements with a brief, repeated plant-based...
Cure8 found this source from medpagetoday.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. Open the original article for the full...
Cure8 found this source from tipranks.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...
Dietary strategies are being studied as active therapies for inducing remission in IBD, not just for symptom control or nutrition. Many patients struggle with malnutrition, and some diets (especially EEN and CDED) have...
Based on the title and source metadata, this appears to be an event or fundraiser related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.
Perianal fistulas are a significant complication of Crohn’s disease that can be hard to treat. A phase 3 trial reported that guselkumab improved combined fistula remission versus placebo, which could represent a new...
Market reports signal where research and new drug investment are going, which can affect future treatment options, drug availability, and pricing. For people living with Crohn’s disease, trends toward more biologics,...
This reports Phase 2b results for a new investigational biologic (JNJ-4804) that targets both IL-23 and TNF and showed higher clinical and endoscopic responses in patients with refractory UC and CD — a group with few...
Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Mirikizumab.
Cure8 could only read part of this source from 1011now.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness.
Based on the title and source metadata, this appears to be a conference abstract related to Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. The original article is from msn.com.
If you had bowel surgery for Crohn’s disease and develop postoperative anastomotic bleeding, this study suggests endoscopic treatment can stop bleeding in most patients and may avoid another operation. Patients who need...
Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Guselkumab.
Cure8 found this source from streetinsider.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Guselkumab. Open the original article for the full details.
Cure8 could only read part of this source from rttnews.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Guselkumab, and IL-23 inhibitor.
Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Inflammatory bowel disease, and Complications. The original article is from cureus.com.
Surgical technique after ileocolic resection may influence how likely Crohn’s disease is to come back near the anastomosis.
New long-term and real-world data about risankizumab and upadacitinib may influence treatment choices and expectations about symptom relief, steroid-sparing effects, treatment persistence, and hospitalization risk for...
This study looks at upadacitinib in people with Crohn’s disease who did not respond to anti-TNF drugs — a common and challenging clinical situation.
Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Risankizumab.
Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...
Starting college brings new routines, living situations, and social pressures that can affect IBD management. Practical planning around food, medications, stress, and support can help reduce the risk of flares and make...
Mucosal healing is a treatment goal that aims to stop internal intestinal inflammation, not just symptoms. Achieving mucosal healing is linked with fewer hospitalizations, less need for surgery, and lower rates of...
Based on the title and source metadata, this appears to be a regulatory update related to Crohn's disease, Inflammatory bowel disease, and Ustekinumab. The original article is from jnj.com.
Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.
This report summarizes recent late-stage trial results, regulatory actions, and new biosimilar launches that could affect treatment options, availability, and drug costs in Crohn’s disease over the coming years.
Market shifts influence availability, cost, and development of new Crohn's disease treatments. Wider use of biosimilars and growth in biologics/small molecules can affect access and treatment choices over time.
Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.
This study tests a live Faecalibacterium prausnitzii probiotic (EXL01) as a way to prolong steroid-induced remission in Crohn’s disease, a potential new strategy to reduce relapses and steroid exposure.
This work targets a possible root cause (epithelial stress and cell death) rather than only suppressing inflammation — if validated in humans, it could offer new treatment options for people who don’t respond to current...
This study suggests a different treatment target for Crohn’s disease: fixing damaged intestinal lining rather than only suppressing inflammation. If validated in humans, repurposed cancer drugs could speed development of...
Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from msn.com.
This study suggests a new treatment angle for Crohn’s disease by targeting epithelial cell stress and barrier repair rather than only dampening immune inflammation. If validated in clinical trials, it could lead to...
A subcutaneous induction option for SKYRIZI could let people with Crohn’s start and continue treatment with injections instead of beginning with an IV infusion, which may affect convenience, time in clinic, and infusion...
The study identifies a specific protein interaction that may underlie persistent inflammation; for people with Crohn’s and other inflammatory conditions this points to a potential new, more targeted treatment approach in...
Based on the title and source metadata, this appears to be a basic science related to Crohn's disease and Research and clinical trials. The original article is from msn.com.
Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.
How “moderate” IBD is defined affects who is enrolled in trials, who is offered advanced therapies, and how clinicians make treatment decisions. Inconsistent definitions could delay appropriate care for people who might...
This analysis summarizes longer-term safety data for upadacitinib (Rinvoq) in people with moderate to severe ulcerative colitis and Crohn’s disease.
Cure8 found this source from abs-cbnnews.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...
The study suggests vitamin D might help the immune system tolerate gut bacteria better and lower intestinal inflammation, which could mean fewer symptoms or flares for people with Crohn’s disease or ulcerative colitis.
Based on the title and source metadata, this appears to be an event or fundraiser related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.
Early clinical data suggest PALI-2108 may affect both inflammation and fibrosis in Crohn’s disease and shows biomarker changes (like fecal calprotectin) that could matter to people monitoring disease activity.
Cure8 found this source from journals.sagepub.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Corticosteroids. Open the original article for the full...
Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.
Cure8 found this source from insidehalton.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the...
